Providing pharmaceutical care during the COVID-19 pandemic: attitudes and experiences of home-treated patients in Jordan

Tareq L Mukattash,Anan S Jarab,Walid Al-Qerem,Rana K Abu Farha,Rania Itani,Samar Karout,Ibrahim L Mukattash,Iman Basheti
DOI: https://doi.org/10.1093/jphsr/rmab010
2021-03-26
Journal of Pharmaceutical Health Services Research
Abstract:Abstract Objectives This study aims to explore home-treated COVID-19 patients’ experiences and perceptions of pharmaceutical care services offered during their sickness. Methods This is a cross-sectional online questionnaire study, where a 30-item questionnaire was texted via a link to COVID-19 patients who were tested positive previously. A list of anonymised numbers was obtained from different COVID-19 testing centres. The study received ethical approval from the Institutional Review Board at the King Abdulla University Hospital/Jordan University of Science and Technology. Key findings A total of 268 patients who were previously diagnosed with COVID-19 agreed to participate in this study. Only 22.9% of patients reported taking medications regularly. Almost one-third of respondents (28.7%) indicated that pharmacists were involved in prescribing medicine to patients. Almost half the respondents (49.6%) stated that they or their caregivers obtained information and advice about their medicine from the pharmacists. Only 54.9% of the respondents agreed/strongly agreed that pharmacists have enough scientific information to provide the necessary medical assistance to COVID-19 patients. Patients who work in the medical field, and who always get their medication from the same pharmacy, showed better perception towards pharmaceutical care services that might be provided to COVID-19 patients (P < 0.01). Conclusions Pharmacists had an unsatisfactory contribution to the management of the disease in outpatient settings. Moreover, there was a poor perception of the pharmacists’ role including their knowledge, communication skills and counselling skills. Thus, it is essential to improve pharmacists’ knowledge and practices about infectious diseases.
What problem does this paper attempt to address?